Modulation of 3H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β-adrenoceptors in mouse tissues

British Journal of Pharmacology

Volumn 130, Issue 2, 2000, Pages 321-330

  Trendelenburg, A U ^a   Cox, S L ^a   Schelb, V ^a   Klebroff, W ^a   Khairallah, L ^a   Starke, K ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Mouse; Noradrenaline release; Opioid receptors; Presynaptic receptors; adrenoceptors

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BRADYKININ RECEPTOR; CANNABINOID RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ICATIBANT; ISOPRENALINE; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NOCICEPTIN; NORADRENALIN; OPIATE RECEPTOR; RIMONABANT; SALBUTAMOL; SR 14176A; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ATRIUM; MALE; MOUSE; NERVE FIBER; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; SPLEEN; SYMPATHETIC NERVE; VAS DEFERENS;

ANIMALS; AXONS; CEREBRAL CORTEX; MALE; MICE; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, BRADYKININ; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, OPIOID; RECEPTORS, PRESYNAPTIC; SPECIES SPECIFICITY; SPLEEN; TRITIUM; VAS DEFERENS;

EID: 0034018966     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703305     Document Type: Article

References (53)

1. 2A-adrenergic receptor knockout mice. Mol. Pharmacol., 56, 154-161.
2. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48-58.
3. BERZETEI-GURSKE, I.P., SCHWARTZ, R.W. & TOLL, L. (1996). Determination of activity for nociceptin in the mouse vas deferens. Eur. J. Pharmacol., 302, RI-R2.
4. 2-selective adrenoceptor antagonist (ICI I18,551). J. Cardiovasc. Pharmacol., 5, 430-437.
5. 1-purinoceptor agonists and antagonists in the mouse vas deferens in vitro. Br. J. Pharmacol., 94, 37-46.
6. CALÒ, G., RIZZI, A., BOGONI, G., NEUGEBAUER, V., SALVADORI, S., GUERRINI, R., BIANCHI, C. & REGOLI, D. (1996). The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur. J. Pharmacol., 311, R3-R5.
7. 2 knockout transgenic mice. Eur. J. Pharmacol., 346, 167-174.
8. COSTA, M. & MAJEWSKI, H. (1991). Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria. Br. J. Pharmacol., 102, 855-860.
9. I/O protein-coupled receptors. Br. J. Pharmacol., 129, 1095-1102.
10. COX, S.L., TRENDELENBURG, A.U. & STARKE, K. (1999). Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br. J. Pharmacol., 127, 1256-1262.
11. DHAWAN, B.N., CESSFLIN, F., RAGHUBIR, R., REISINE, T., BRADLEY, P.B., PORTOGHESE, P.S. & HAMON, M. (1996). International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 48, 567-592.
12. 2 subtype. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 564-571.
13. EMMERSON. P.J., LIU, M.R., WOODS, J.H. & MEDZIHRADSKY, F. (1994). Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J. Pharmacol. Exp. Ther., 271, 1630-1637.
14. ENDO, T., STARKE, K., BANGERTER, A. & TAUBE, H.D. (1977). Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 296, 229-247.
15. 2 on noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 46-52.
16. FALCONE. R.C., HUBBS, S.J., VANDERLOO, J.D., PROSSER, J.C., LITTLE, J., GOMES, B., AHARONY, D. & KRELL, R.D. (1993). Characterization of bradykinin receptors in guinea pig gall bladder. J. Pharmacol. Exp. Ther., 266, 1291-1299.
17. FOUCART, S. & MAJEWSKI, H. (1989). Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 658-665.
18. FUDER, H. & MUSCHOLL, E. (1995). Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev. Physiol. Biochem. Pharmacol., 126, 265-412.
19. GUERRINI, R., CALO, G., RIZZI, A., BIGONI, R., BIANCHI, C., SALVADORI, S. & REGOLI, D. (1998). A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol., 123, 163-165.
20. 2-adrenergic receptors regulate sympathetic neurotransmission. Nature, 402, 181-184.
21. HENDERSON, G., HUGHES, J. & KOSTERLITZ, H.W. (1972). A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br. J. Pharmacol., 46, 764-766.
22. HENDERSON, G. & McKNIGHT, A.T. (1997). The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol. Sci., 18, 293-300.
23. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
24. ILLES, P. (1989). Modulation of transmitter and hormone release by multiple neuronal opioid receptors. Rev. Physiol. Biochem. Pharmacol., 112, 139-233.
25. 1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 2023-2028.
26. JOHNSTON, H. & MAJEWSKI, H. (1986). Prejunctional β-adrenoceptors in rabbit pulmonary artery and mouse atria: effect of α-adrenoceptor blockade and phosphodiesterase inhibition. Br. J. Pharmacol., 87, 553-562.
27. LANGER, S.Z. (1981). Presynaptic regulation of the release of catecholamincs. Pharmacol Rev., 32, 337-362.
28. 2D-autoreceptors in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 43-48.
29. LLONA, I., GALLEGUILLOS, X., BELMAR, J. & HUIDOBRO-TORO, J.P. (1991). Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals. Life Sci., 48, 2585-2592.
30. MAJEWSKI, H. (1983). Modulation of noradrenaline release through activation of presynaptic β-adrenoreceptors. J. Auton. Pharmacol., 3, 47-60.
31. 2-adrenoceptors on the sympathetic nerve fibres of the human saphenous vein: no evidence for involvement in adrenaline-mediated positive feedback loop regulating noradrenergic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol., 337, 408-414.
32. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 2199-2205.
33. PERTWEE, R.G., GRIFFIN, G., LAINTON, J.A.H. & HUFFMAN, J.W. (1995). Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur. J. Pharmacol., 284, 241-247.
34. PERTWEE, R.G., STEVENSON, L.A., ELRICK, D.B., MECHOULAM, R. & CORBETT, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980-984.
35. RAJANAYAGAM, M.A.S., MUSGRAVE, I.F., RAND, M.J. & MAJEWSKI, H. (1989). Facilitation of noradrenaline release by isoprenaline is not mediated by angiotensin II in mouse atria and rat tail artery. Arch. Int. Pharmacodyn., 299, 185-199.
36. 2-adrenoceptors permits the operation of otherwise silent opioid κ-receptors at the sympathetic axons of rabbit jejunal arteries. Naunyn-Schmiedeberg's Arch. Pharmacol., 334, 48-55.
37. RINALDI-CARMONA, M., BARTH, E., HÉAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NÉLIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÈRE, J.C. & LE FUR, G. (1994). SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letts., 350, 240-244.
38. RUMP, L.C., BERLIT, T., SCHWERTFEGER, E., BEYERSDORF, F., SCHOLLMEYER, P. & BOHMANN, C. (1997). Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium. J. Hypertension, 15, 1263-1270.
39. 3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 489-493.
40. 2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res. Bull., 47, 129 132.
41. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 583-589.
42. 1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 418-422.
43. 2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Circ. Res., 81, 774-784.
44. SINGER, E.A. (1988). Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol. Sci., 9, 274-276.
45. STARKE, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol., 77, 1-124.
46. STARKE, K., PESKAR, B.A., SCHUMACHER, K.A. & TAUBE, H.D. (1977). Bradykinin and postganglionic sympathetic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol., 299, 23-32.
47. 2A, D-adrenoceptor-deficient mice. Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 540-551.
48. 2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 721-737.
49. VAZ-DA-SILVA, M., MAGINA, S., DOMINGUES-COSTA, A., MOURA, D. & GUIMARÄES, S. (1996). The role of the endocardium in the facilitatory effect of bradykinin on electrically-induced release of noradrenaline in rat cardiac ventricle. Br. J. Pharmacol., 118, 364-368.
50. 2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 522-532.
51. 2D subtype. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 253-261.
52. WAUD D.R. (1976). Analysis of dose-response relationships. In: Advances in general and cellular pharmacology. Vol 1. ed. Narahshi, T. & Bianchi, C.P. pp 145-178. New York, London: Plenum.
53. WILD, K.D., CARLISI, V.J., MOSBERG, H.I., BOWEN, W.D., PORTOGHESE, P.S., SULTANA, M., TAKEMORI, A.E., HRUBY, V.J. & PORRECA, F. (1993). Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens. J. Pharmacol. Exp. Ther., 264, 831-838.